Hycamtin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8158645 NOVARTIS Compound, corresponding compositions, preparation and/or treatment methods
Dec, 2024

(1 year, 2 months from now)

Hycamtin is owned by Novartis.

Hycamtin contains Topotecan Hydrochloride.

Hycamtin has a total of 1 drug patent out of which 0 drug patents have expired.

Hycamtin was authorised for market use on 11 October, 2007.

Hycamtin is available in capsule;oral dosage forms.

The generics of Hycamtin are possible to be released after 10 December, 2024.

Drugs and Companies using TOPOTECAN HYDROCHLORIDE ingredient

Market Authorisation Date: 11 October, 2007

Treatment: NA


More Information on Dosage

HYCAMTIN family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic